CALMARE THERAPEUTICS INC: 10-Q/A filed 2011-08-18
What CALMARE THERAPEUTICS INC reported in its quarterly report amendment filed 2011-08-18 (fiscal Q2 2011): 26 published measures, 72 facts as tagged in accession 0001360865-11-000132.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2011-08-18
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001360865-11-000132 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CALMARE THERAPEUTICS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,273,832 | USD | |
| At 2010-12-31 | 3,195,543 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -16,629 | USD | |
| At 2010-12-31 | 651,360 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 315,507 | USD | |
| At 2010-12-31 | 557,018 | USD | |
| At 2010-07-31 | 907,484 | USD | |
| At 2010-01-31 | 1,081,328 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -1,334,829 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,305,395 | USD | 181 |
| 2010-05-01 to 2010-07-31 | -468,245 | USD | 92 |
| 2010-02-01 to 2010-07-31 | -1,207,710 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -278,671 | USD | 181 |
| 2010-02-01 to 2010-07-31 | -2,085,629 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -14,415 | USD | 181 |
| 2010-02-01 to 2010-07-31 | -14,581 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 10,050 | USD | 181 |
| 2010-02-01 to 2010-07-31 | 1,926,366 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 27,110 | USD | 181 |
| 2010-02-01 to 2010-07-31 | -14,581 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -44,315,448 | USD | |
| At 2010-12-31 | -43,010,053 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 13,747,028 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 13,862,274 | shares | 181 |
| 2010-05-01 to 2010-07-31 | 11,867,328 | shares | 92 |
| 2010-02-01 to 2010-07-31 | 11,468,700 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 13,747,028 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 13,862,274 | shares | 181 |
| 2010-05-01 to 2010-07-31 | 11,867,328 | shares | 92 |
| 2010-02-01 to 2010-07-31 | 11,468,700 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -0.1 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | -0.09 | USD/shares | 181 |
| 2010-05-01 to 2010-07-31 | -0.04 | USD/shares | 92 |
| 2010-02-01 to 2010-07-31 | -0.11 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -0.1 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | -0.09 | USD/shares | 181 |
| 2010-05-01 to 2010-07-31 | -0.04 | USD/shares | 92 |
| 2010-02-01 to 2010-07-31 | -0.11 | USD/shares | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 32,495 | USD | |
| At 2010-12-31 | 40,642 | USD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,224,062 | USD | |
| At 2010-12-31 | 3,139,901 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 10,374 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 19,990 | USD | 181 |
| 2010-05-01 to 2010-07-31 | 1,695 | USD | 92 |
| 2010-02-01 to 2010-07-31 | 3,533 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,290,461 | USD | |
| At 2010-12-31 | 2,544,183 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 189,100 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,159,402 | USD | 181 |
| 2010-05-01 to 2010-07-31 | 649,862 | USD | 92 |
| 2010-02-01 to 2010-07-31 | 1,059,099 | USD | 181 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 44,096,044 | USD | |
| At 2010-12-31 | 43,484,989 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 644,509 | USD | |
| At 2010-12-31 | 407,123 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 80,622 | USD | |
| At 2010-12-31 | 77,952 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -1,334,829 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,305,395 | USD | 181 |
| 2010-05-01 to 2010-07-31 | -468,245 | USD | 92 |
| 2010-02-01 to 2010-07-31 | -1,207,710 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -1,305,395 | USD | 181 |
| 2010-02-01 to 2010-07-31 | -1,207,710 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 996,844 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,513,482 | USD | 181 |
| 2010-05-01 to 2010-07-31 | 498,513 | USD | 92 |
| 2010-02-01 to 2010-07-31 | 1,070,186 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 13,490 | USD | 181 |
| 2010-02-01 to 2010-07-31 | 26,353 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -2,220,227 | USD | 181 |
| 2010-02-01 to 2010-07-31 | 160,883 | USD | 181 |
Inspect the source
- Entity
- CALMARE THERAPEUTICS INC / CIK 0000102198
- Captured
- SEC response SHA-256
0ebcc84665a429c0cdf4445786085ba38ea38f61d1d9b78a273e6ff2088597c3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000102198.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))